Logo image of UFPT

UFP TECHNOLOGIES INC (UFPT) Stock Fundamental Analysis

NASDAQ:UFPT - Nasdaq - US9026731029 - Common Stock - Currency: USD

247.47  +2.77 (+1.13%)

Fundamental Rating

6

Overall UFPT gets a fundamental rating of 6 out of 10. We evaluated UFPT against 187 industry peers in the Health Care Equipment & Supplies industry. While UFPT belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. UFPT is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one! This makes UFPT very considerable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

UFPT had positive earnings in the past year.
In the past year UFPT had a positive cash flow from operations.
Each year in the past 5 years UFPT has been profitable.
Each year in the past 5 years UFPT had a positive operating cash flow.
UFPT Yearly Net Income VS EBIT VS OCF VS FCFUFPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

UFPT has a Return On Assets of 9.88%. This is amongst the best in the industry. UFPT outperforms 93.05% of its industry peers.
UFPT has a better Return On Equity (17.60%) than 91.98% of its industry peers.
Looking at the Return On Invested Capital, with a value of 13.23%, UFPT belongs to the top of the industry, outperforming 95.19% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for UFPT is above the industry average of 7.89%.
The last Return On Invested Capital (13.23%) for UFPT is above the 3 year average (11.64%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.88%
ROE 17.6%
ROIC 13.23%
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
UFPT Yearly ROA, ROE, ROICUFPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

UFPT's Profit Margin of 11.59% is amongst the best of the industry. UFPT outperforms 88.24% of its industry peers.
In the last couple of years the Profit Margin of UFPT has grown nicely.
UFPT has a Operating Margin of 16.57%. This is amongst the best in the industry. UFPT outperforms 87.70% of its industry peers.
In the last couple of years the Operating Margin of UFPT has grown nicely.
UFPT has a Gross Margin of 28.99%. This is in the lower half of the industry: UFPT underperforms 75.40% of its industry peers.
In the last couple of years the Gross Margin of UFPT has remained more or less at the same level.
Industry RankSector Rank
OM 16.57%
PM (TTM) 11.59%
GM 28.99%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
UFPT Yearly Profit, Operating, Gross MarginsUFPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UFPT is creating some value.
UFPT has more shares outstanding than it did 1 year ago.
UFPT has more shares outstanding than it did 5 years ago.
UFPT has a worse debt/assets ratio than last year.
UFPT Yearly Shares OutstandingUFPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
UFPT Yearly Total Debt VS Total AssetsUFPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

2.2 Solvency

UFPT has an Altman-Z score of 6.27. This indicates that UFPT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of UFPT (6.27) is better than 83.42% of its industry peers.
The Debt to FCF ratio of UFPT is 3.10, which is a good value as it means it would take UFPT, 3.10 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of UFPT (3.10) is better than 88.24% of its industry peers.
UFPT has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.47, UFPT is in line with its industry, outperforming 43.32% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.1
Altman-Z 6.27
ROIC/WACC1.49
WACC8.86%
UFPT Yearly LT Debt VS Equity VS FCFUFPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

A Current Ratio of 2.58 indicates that UFPT has no problem at all paying its short term obligations.
The Current ratio of UFPT (2.58) is comparable to the rest of the industry.
UFPT has a Quick Ratio of 1.45. This is a normal value and indicates that UFPT is financially healthy and should not expect problems in meeting its short term obligations.
UFPT has a Quick ratio of 1.45. This is comparable to the rest of the industry: UFPT outperforms 40.11% of its industry peers.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 1.45
UFPT Yearly Current Assets VS Current LiabilitesUFPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 31.35% over the past year.
UFPT shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 23.55% yearly.
UFPT shows a strong growth in Revenue. In the last year, the Revenue has grown by 34.43%.
UFPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.52% yearly.
EPS 1Y (TTM)31.35%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%34.76%
Revenue 1Y (TTM)34.43%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.08%

3.2 Future

The Earnings Per Share is expected to grow by 14.28% on average over the next years. This is quite good.
The Revenue is expected to grow by 9.93% on average over the next years. This is quite good.
EPS Next Y16.76%
EPS Next 2Y14.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue Next Year20.35%
Revenue Next 2Y12.73%
Revenue Next 3Y9.93%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
UFPT Yearly Revenue VS EstimatesUFPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M
UFPT Yearly EPS VS EstimatesUFPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 30.29 indicates a quite expensive valuation of UFPT.
Compared to the rest of the industry, the Price/Earnings ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 76.47% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of UFPT to the average of the S&P500 Index (27.93), we can say UFPT is valued inline with the index average.
With a Price/Forward Earnings ratio of 24.79, UFPT is valued on the expensive side.
Compared to the rest of the industry, the Price/Forward Earnings ratio of UFPT indicates a somewhat cheap valuation: UFPT is cheaper than 74.87% of the companies listed in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 37.78. UFPT is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 30.29
Fwd PE 24.79
UFPT Price Earnings VS Forward Price EarningsUFPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, UFPT is valued a bit cheaper than 75.94% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, UFPT is valued cheaper than 80.21% of the companies in the same industry.
Industry RankSector Rank
P/FCF 32.33
EV/EBITDA 19.19
UFPT Per share dataUFPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of UFPT may justify a higher PE ratio.
UFPT's earnings are expected to grow with 14.28% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.81
PEG (5Y)1.29
EPS Next 2Y14.6%
EPS Next 3Y14.28%

0

5. Dividend

5.1 Amount

No dividends for UFPT!.
Industry RankSector Rank
Dividend Yield N/A

UFP TECHNOLOGIES INC

NASDAQ:UFPT (7/29/2025, 10:23:40 AM)

247.47

+2.77 (+1.13%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)05-06 2025-05-06/bmo
Earnings (Next)08-05 2025-08-05
Inst Owners110.86%
Inst Owner Change1.38%
Ins Owners3.69%
Ins Owner Change4.24%
Market Cap1.91B
Analysts78
Price Target317.22 (28.19%)
Short Float %19.05%
Short Ratio7.99
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.07%
Min EPS beat(2)3.81%
Max EPS beat(2)8.33%
EPS beat(4)4
Avg EPS beat(4)9.7%
Min EPS beat(4)3.81%
Max EPS beat(4)14.29%
EPS beat(8)7
Avg EPS beat(8)15.09%
EPS beat(12)11
Avg EPS beat(12)31.68%
EPS beat(16)14
Avg EPS beat(16)26.54%
Revenue beat(2)1
Avg Revenue beat(2)1.69%
Min Revenue beat(2)-0.3%
Max Revenue beat(2)3.67%
Revenue beat(4)3
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-0.3%
Max Revenue beat(4)7.43%
Revenue beat(8)6
Avg Revenue beat(8)2.62%
Revenue beat(12)10
Avg Revenue beat(12)5.5%
Revenue beat(16)14
Avg Revenue beat(16)5.64%
PT rev (1m)0%
PT rev (3m)-18.37%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.06%
EPS NY rev (1m)0%
EPS NY rev (3m)-1%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)4.45%
Revenue NY rev (1m)0%
Revenue NY rev (3m)2.73%
Valuation
Industry RankSector Rank
PE 30.29
Fwd PE 24.79
P/S 3.48
P/FCF 32.33
P/OCF 27.36
P/B 5.29
P/tB 69.51
EV/EBITDA 19.19
EPS(TTM)8.17
EY3.3%
EPS(NY)9.98
Fwd EY4.03%
FCF(TTM)7.65
FCFY3.09%
OCF(TTM)9.05
OCFY3.66%
SpS71.02
BVpS46.78
TBVpS3.56
PEG (NY)1.81
PEG (5Y)1.29
Profitability
Industry RankSector Rank
ROA 9.88%
ROE 17.6%
ROCE 16.13%
ROIC 13.23%
ROICexc 13.57%
ROICexgc 34.55%
OM 16.57%
PM (TTM) 11.59%
GM 28.99%
FCFM 10.78%
ROA(3y)10.52%
ROA(5y)8.58%
ROE(3y)16.84%
ROE(5y)13.25%
ROIC(3y)11.64%
ROIC(5y)9.67%
ROICexc(3y)11.86%
ROICexc(5y)10.07%
ROICexgc(3y)27.75%
ROICexgc(5y)22.85%
ROCE(3y)14.19%
ROCE(5y)11.78%
ROICexcg growth 3Y28.55%
ROICexcg growth 5Y9.48%
ROICexc growth 3Y27.39%
ROICexc growth 5Y1.08%
OM growth 3Y16.51%
OM growth 5Y5.87%
PM growth 3Y14.91%
PM growth 5Y3.22%
GM growth 3Y5.49%
GM growth 5Y1.33%
F-Score4
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF 3.1
Debt/EBITDA 1.59
Cap/Depr 65.69%
Cap/Sales 1.96%
Interest Coverage 9.01
Cash Conversion 65.12%
Profit Quality 92.97%
Current Ratio 2.58
Quick Ratio 1.45
Altman-Z 6.27
F-Score4
WACC8.86%
ROIC/WACC1.49
Cap/Depr(3y)91.16%
Cap/Depr(5y)78.11%
Cap/Sales(3y)2.81%
Cap/Sales(5y)2.7%
Profit Quality(3y)58.22%
Profit Quality(5y)76.97%
High Growth Momentum
Growth
EPS 1Y (TTM)31.35%
EPS 3Y53.29%
EPS 5Y23.55%
EPS Q2Q%34.76%
EPS Next Y16.76%
EPS Next 2Y14.6%
EPS Next 3Y14.28%
EPS Next 5YN/A
Revenue 1Y (TTM)34.43%
Revenue growth 3Y34.72%
Revenue growth 5Y20.52%
Sales Q2Q%41.08%
Revenue Next Year20.35%
Revenue Next 2Y12.73%
Revenue Next 3Y9.93%
Revenue Next 5YN/A
EBIT growth 1Y49.25%
EBIT growth 3Y56.96%
EBIT growth 5Y27.59%
EBIT Next Year48.19%
EBIT Next 3Y23.44%
EBIT Next 5YN/A
FCF growth 1Y552.02%
FCF growth 3Y85.71%
FCF growth 5Y17.47%
OCF growth 1Y207.54%
OCF growth 3Y67.03%
OCF growth 5Y16.35%